CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Cefepime And Dextrose In Duplex Container patents expire, and what generic alternatives are available?
Cefepime And Dextrose In Duplex Container is a drug marketed by B Braun and is included in one NDA.
The generic ingredient in CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER is cefepime hydrochloride. There are twenty drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the cefepime hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cefepime And Dextrose In Duplex Container
A generic version of CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER was approved as cefepime hydrochloride by ACS DOBFAR on March 20th, 2008.
Summary for CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER at DailyMed |
Pharmacology for CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER
Drug Class | Cephalosporin Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER
US Patents and Regulatory Information for CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B Braun | CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER | cefepime hydrochloride | INJECTABLE;INJECTION | 050821-001 | May 6, 2010 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
B Braun | CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER | cefepime hydrochloride | INJECTABLE;INJECTION | 050821-002 | May 6, 2010 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |